AR and Alzheimer disease: Thus, possible use of NET and MAO inhibitors in the treatment of AD will need much more investigation, as chronic elevation of NE may lead to receptor desensitization, and the role of each α and β AR subtype in modulating hippocampal function and learning and memory is complex.